Skip to main content

About CRUK Scotland Institute

Find out what we do, how we do it and why we do what we do.

A person walks across a city street at sunset, with tall buildings lining the road on both sides.

Life in Glasgow

Find out about living and working in Glasgow and Scotland.

Our Research

Explore the science at CRUK Scotland Institute. Our research groups, the people who lead them, and how we work.

Operations

The teams and services that keep the Institute running and support our research.

Partners

The networks and organisations we work with to accelerate cancer research.

Careers & Study

Jobs, studentships and opportunities for students at every stage at our world-renowned cancer research institute.

Studentships

PhD opportunities at the Institute

Studentship Vacancies

Open studentships to apply for

Internships

For undergraduate and masters students

ColoRectal Cancer – Stratification of Therapies through Adaptive Responses (CRC‑STARS)

A five-year international research project investigating how different bowel cancers respond to current treatments, why certain bowel cancers spread, and whether we can predict which treatments will work for individual patients.

Six colourful abstract human figures form a star shape around the red text CRC-STARS in the centre, on a white background.

Years

Institutes

Researchers

Funding

Clinical Trials

Funders

Stratifying therapy through adaptive response

Colorectal cancer (CRC) remains the second most common cause of cancer death. It presents an opportunity for precision medicine: it is common, has known driver molecular pathways, and pre-treatment molecular stratification is achievable.
Recent single-cell studies show CRC tumours are made up of multiple populations within a complex microenvironment. In addition, data from preclinical models show tumour cells are highly plastic, adapting to therapy in ways that may underpin both response and resistance.

The project

The aim of the project is to test recent discoveries from pre-clinical models in patient samples from 3 neo-adjuvant clinical trials; FOxTROT, TREC and PRIME-RT.  Serial sampling (blood and tumour) will be analysed using state of the art technologies and correlated to response which can then be re-tested in laboratory models and re-interrogated in clinical data.  The team believe that by using this “bedside, to bench, and back to bedside” approach to understanding how cancer behaves at a molecular and cellular level will allow us to personalise CRC treatment in the future. 

Leadership

Owen Sansom

Network Lead

CRUK Scotland Institute, Glasgow

Jenny Seligmann

Co-Lead

University of Leeds

Simon Leedham

Co-Lead

University of Oxford

Jointly funded, awarded March 2025

Over 50 researchers with expertise in different disciplines, at institutes across the UK, Spain (Spanish Association Against Cancer Scientific Foundation), Italy and Belgium.

Cancer Research UK logo with a large C made of pink and blue dots, next to the words Cancer Research UK in black text on a white background.
Bowelbabe Fund logo with a purple B in a circle and the words Bowelbabe Fund for Cancer Research UK in purple and grey text.
Logo of Fundación Científica Asociación Española Contra el Cáncer, with a green symbol and text in green and black.

Project Coordinator — Fiona Paulin-Ali
For enquiries about the CRC-STARS programme, get in touch.
Email me

Secret Link